Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-14

Clinical Trial Update: Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial [Phase 2]

View source ↗

Summary

This document describes a Phase 2 multicenter, double-blind, placebo-controlled trial evaluating an acetylcholinesterase inhibitor for anorexia nervosa (restric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetylcholinesterase inhibitor

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Anorexia Nervosa Restricting Type | Phase 2 | Status: NOT_YET_RECRUITING